(S (NP-SBJ-38 (JJ Epstein-Barr) (JJ viral) (NN latency)) (VP (VBZ is) (VP (VBN disrupted) (NP (-NONE- *-38)) (PP (IN by) (NP-LGS (DT the) (JJ immediate-early) (NN BRLF1) (NN protein))) (PP (IN through) (NP (DT a) (JJ cell-specific) (NN mechanism))))) (. .))
(S (NP-SBJ (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (, ,) (NP (NP (DT the) (JJ causative) (NN agent)) (PP (IN of) (NP (JJ infectious) (NN mononucleosis)))) (, ,)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ human) (NN herpesvirus)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (NP (JJ epithelial) (NN cell) (NNS malignancies)) (PRN (-LRB- -LRB-) (NP (JJ nasopharyngeal) (NN carcinoma)) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (NN B-cell) (NNS malignancies))))))) (. .))
(S (S-SBJ (NP-SBJ (-NONE- *)) (VP (VBG Understanding) (SBAR (WHADVP-39 (WRB how)) (S (NP-SBJ-40 (JJ viral) (NN latency)) (VP (VBZ is) (VP (VBN disrupted) (NP (-NONE- *-40)) (ADVP (-NONE- *T*-39)))))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ central) (NN issue)) (PP (IN in) (NP (JJ herpesvirus) (NN biology))))) (. .))
(S-COOD (S (NP-SBJ (JJ Epithelial) (NNS cells)) (VP (VBP are) (NP-PRD (NP (DT the) (JJ major) (NN site)) (PP (IN of) (NP (NP (JJ lytic) (NN EBV) (NN replication)) (PP (IN within) (NP (DT the) (JJ human) (NN host)))))))) (, ,) (CC and) (S (NP-SBJ (JJ viral) (NN reactivation)) (VP (VBZ occurs) (PP (IN in) (NP (JJ EBV-associated) (JJ nasopharyngeal) (NNS carcinomas))))) (. .))
(S (NP-SBJ (PRP It)) (VP (VBZ is) (VP (VBN known) (SBAR (IN that) (S (NP-SBJ (NP (NN expression)) (PP (IN of) (NP (NP (DT a) (JJ single) (JJ viral) (JJ immediate-early) (NN protein)) (, ,) (NP (NN BZLF1)) (, ,)))) (VP (VBZ is) (ADJP-PRD (JJ sufficient) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB initiate) (NP (NP (DT the) (NN switch)) (PP (IN from) (NP (JJ latent) (NP (-NONE- *RNR*-41)))) (PP (TO to) (NP (JJ lytic) (NP (-NONE- *RNR*-41)))) (NP-41 (NN infection)) (PP (IN in) (NP (NN B) (NNS cells))))))))))))) (. .))
(S (NP-SBJ-42 (NP (JJ Cellular) (NN regulation)) (PP (IN of) (NP (NN BZLF1) (NN transcription)))) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN thought) (S (NP-SBJ-43 (-NONE- *-42)) (VP (TO to) (VP (VB play) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (S (NP-SBJ (-NONE- *-43)) (VP (VBG regulating) (NP (NP (DT the) (NN stringency)) (PP (IN of) (NP (JJ viral) (NN latency)))))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (, ,) (S (ADVP (RB unexpectedly)) (, ,) (NP-SBJ (NP (NN expression)) (PP (IN of) (NP (NP (DT another) (JJ viral) (JJ immediate-early) (NN protein)) (, ,) (NP (NN BRLF1)) (, ,)))) (VP (MD can) (VP (VB disrupt) (NP (JJ viral) (NN latency)) (PP (IN in) (NP (DT an) (ADJP (JJ epithelial) (JJ cell-specific)) (NN fashion)))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ-44 (NP (DT the) (NNS mechanisms)) (VP (VBG leading) (PP (TO to) (NP (NP (NN disruption)) (PP (IN of) (NP (NN EBV) (NN latency))))))) (VP (VBP appear) (S (NP-SBJ (-NONE- *-44)) (VP (TO to) (VP (VB be) (ADJP-PRD (NN cell-type) (JJ specific)))))) (. .))
